The Healing Stack: BPC-157 + TB-500

Ask ten long-time peptide users which combo they'd grab on a desert island and eight of them name this one. BPC-157 and TB-500 is the stack that built the community's reputation for moving the needle on stubborn soft-tissue problems — the partially torn supraspinatus that's been grumbling for two years, the golfer's elbow that won't quit, the post-surgical scar tissue that everyone said you'd just have to live with.

It isn't a miracle. It's a two-peptide protocol with a clear mechanistic story and a long anecdote trail.

Who this is for

• A nagging tendon, ligament, or joint injury that hasn't fully resolved with rest and rehab
• Post-surgical recovery where you want to accelerate the repair window
• Chronic soft-tissue inflammation that imaging can't fully explain

This is not a performance stack. It's a repair stack.

The compounds

• BPC-157 — 250-500 mcg, 1-2x per day, sub-Q. Local to the injury site if feasible.
• TB-500 — 2.5 mg loading dose 2x per week for weeks 1-4, then 2.5 mg 1x per week for weeks 5-8. Sub-Q, any site.

Eight weeks is the typical window. A few people push to twelve; most don't.

Weekly schedule

Day	Morning	Evening
Mon	BPC-157 250 mcg + TB-500 2.5 mg	BPC-157 250 mcg
Tue	BPC-157 250 mcg	BPC-157 250 mcg
Wed	BPC-157 250 mcg	BPC-157 250 mcg
Thu	BPC-157 250 mcg + TB-500 2.5 mg	BPC-157 250 mcg
Fri	BPC-157 250 mcg	BPC-157 250 mcg
Sat	BPC-157 250 mcg	BPC-157 250 mcg
Sun	BPC-157 250 mcg	BPC-157 250 mcg

After week 4, drop TB-500 to once a week (keep Monday, skip Thursday) and hold BPC-157 steady.

Why the two together

BPC-157 is the repair signal — angiogenesis, growth-factor receptor upregulation, local tissue response. TB-500 is the logistics team — actin regulation, cell migration, getting the right cells to where the work is. One tells the tissue to heal. The other tells the cells where to show up.

They're not redundant. That's why people run them together instead of picking one.

Ramp-up and taper

There's no ramp on BPC-157 — most people start at the target dose. If you're new to peptides, begin at 250 mcg once daily for the first week just to confirm no injection-site issues, then add the second dose.

TB-500 has a built-in taper: the front-loaded weeks 1-4 saturate the system, then the lower maintenance dose holds. At the end of week 8, stop. No wind-down needed.

What to expect

• Week 1-2: Usually nothing dramatic. Some people report slightly warmer or more "alive-feeling" tissue near the injury. Others notice nothing until week three.
• Week 3-4: This is where most people mark the shift. Morning stiffness lifting, range of motion returning, pain at the edges dulling.
• Week 5-6: The injury feels more stable under load. This is where you can start progressive loading if you've been holding back.
• Week 7-8: Diminishing returns territory. If you're not seeing continued improvement, stopping is reasonable.

People who respond tend to respond in this window. If week six comes and nothing has moved, the stack probably isn't solving your problem and you should look upstream — mechanical cause, systemic inflammation, sleep.

Cost ballpark

At community supplier pricing, an eight-week course lands somewhere around $180-300 depending on source and format. TB-500 is the more expensive component. Reconstitution supplies (bac water, syringes, alcohol wipes) add another $20-40.

Red flags — when to stop

• Persistent injection-site reactions beyond the first week
• New, unexplained headaches or dizziness that don't resolve with dose reduction
• Any sign of infection at an injection site — warmth, streaking redness, fever
• No measurable improvement by week six despite consistent dosing

Stopping mid-cycle is fine. Neither peptide has a withdrawal profile.

Where to go next

• The BPC-157 field guide covers dosing debates and the local-vs-systemic question in depth.
• For deeper mechanism and study citations, see the Pepperpedia BPC-157 entry and TB-500 entry.
• The 8-week post-injury recovery protocol is the structured version of this stack for a specific injury.
• Real protocols, real outcomes — the Protocol Discussions forum.